Maze Therapeutics Appoints Sekar Kathiresan, M.D., to its Board of Directors   SOUTH SAN FRANCISCO, CA., Sept. 22, 2022 – Maze Therapeutics, a company translating genetic insights into new precision medicines, today announced that Sekar Kathiresan, M.D., a Maze co-founder,…